Inhaled nebulised unfractionated heparin improves lung function in moderate to very severe COPD: A pilot study-Reference-Cited by-同舟云学术

Inhaled nebulised unfractionated heparin improves lung function in moderate to very severe COPD: A pilot study

Published:2018-02 Issue: Volume:48 Page:88-96
ISSN:1094-5539
Container-title:Pulmonary Pharmacology & Therapeutics
language:en
Short-container-title:Pulmonary Pharmacology & Therapeutics

Author:

Shute Janis K.,Calzetta Luigino,Cardaci Vittorio,di Toro Stefania,Page Clive P.,Cazzola Mario

Publisher

Elsevier BV

Subject

Pharmacology (medical),Biochemistry (medical),Pulmonary and Respiratory Medicine

Reference60 articles.

1. BOLD Collaborative Research Group. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study;Buist;Lancet,2007

2. Treatment options for moderate-to-very severe chronic obstructive pulmonary disease;Cazzola;Expert Opin. Pharmacother.,2016

3. Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD, Updated 2015);GOLD,2015

4. Bronchodilators: current and future;Cazzola;Clin. Chest Med.,2014

5. Pharmacological interaction between LABAs and LAMAs in the airways: optimizing synergy;Calzetta;Eur. J. Pharmacol.,2015

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mucoactive drugs and multiple applications in pulmonary disease therapy;European Journal of Pharmaceutics and Biopharmaceutics;2024-01

2. Targeting biophysical microenvironment for improved treatment of chronic obstructive pulmonary disease;Trends in Molecular Medicine;2023-11

3. Efficacy and safety of inhaled heparin in asthmatic and chronic obstructive pulmonary disease patients: a systematic review and a meta-analysis;Scientific Reports;2023-08-16

4. The role of neutrophils and neutrophil extracellular traps in renal diseases of bacterial origin;Česko-slovenská pediatrie;2023-07-01

5. Inhaled nebulised unfractionated heparin (UFH) for the treatment of hospitalised patients with COVID-19: A randomised controlled pilot study;Pulmonary Pharmacology & Therapeutics;2023-06